| Revision as of 10:22, 21 November 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{drugbox}} taken from revid 461572631 of page Ardeparin_sodium for the Chem/Drugbox validation project (updated: 'DrugBank', 'UNII', 'ChEMBL'). |
Latest revision as of 05:47, 1 July 2024 edit Citation bot (talk | contribs)Bots5,418,198 edits Added date. | Use this bot. Report bugs. | Suggested by Whywhenwhohow | #UCB_webform 94/1421 |
| Line 1: |
Line 1: |
|
|
{{Short description|Pharmaceutical drug}} |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
|
{{Use dmy dates|date=March 2024}} |
|
{{Drugbox |
|
{{Drugbox |
|
| Verifiedfields = changed |
|
| Verifiedfields = changed |
|
| Watchedfields = changed |
|
| Watchedfields = changed |
|
| verifiedrevid = 457813015 |
|
| verifiedrevid = 461745594 |
|
| IUPAC_name = 6-oxy-3-[5-(6- |
|
| IUPAC_name = 6-oxy-3-[5-(6- |
|
| image = Ardeparin.png |
|
| image = Ardeparin.png |
|
| width = 450 |
|
| width = 450 |
|
|
| alt = |
|
|
|
|
|
<!--Clinical data--> |
|
<!-- Clinical data --> |
|
| tradename = |
|
| tradename = |
|
| Drugs.com = {{drugs.com|MTM|ardeparin_sodium}} |
|
| Drugs.com = {{drugs.com|MTM|ardeparin}} |
|
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_category = |
|
| pregnancy_US = C |
|
|
⚫ |
| routes_of_administration = Injection |
| ⚫ |
| pregnancy_category = |
|
|
|
| ATC_prefix = None |
|
⚫ |
| ATC_suffix = |
|
|
|
|
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
| legal_US = Rx-only |
|
|
| legal_US_comment = |
|
| legal_status = Withdrawn |
|
| legal_status = |
| ⚫ |
| routes_of_administration = |
|
|
|
|
|
|
<!--Pharmacokinetic data--> |
|
<!-- Pharmacokinetic data --> |
|
| bioavailability = 92% |
|
| bioavailability = 92% |
|
| protein_bound = |
|
| protein_bound = |
|
| metabolism = |
|
| metabolism = |
|
| elimination_half-life = |
|
| elimination_half-life = |
|
| excretion = |
|
| excretion = |
|
|
|
|
|
<!--Identifiers--> |
|
<!-- Identifiers --> |
|
| CAS_number_Ref = {{cascite|correct|??}} |
|
| CAS_number_Ref = {{cascite|correct|CAS}} |
|
| CAS_number = |
|
| CAS_number = 9041-08-1 |
|
| ATC_prefix = none |
|
| PubChem = |
| ⚫ |
| ATC_suffix = |
|
|
| PubChem = |
|
|
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} |
|
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} |
|
| DrugBank = <!-- blanked - oldvalue: DB00407 --> |
|
| DrugBank = DB00407 |
| ⚫ |
| UNII_Ref = {{fdacite|changed|FDA}} |
|
|
| UNII = <!-- blanked - oldvalue: N3927D01PB --> |
|
| ⚫ |
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL = <!-- blanked - oldvalue: 1201448 --> |
|
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
| ChemSpiderID = NA |
|
| ChemSpiderID = none |
|
⚫ |
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = N3927D01PB |
|
⚫ |
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL = 1201448 |
|
|
|
|
|
<!--Chemical data--> |
|
<!-- Chemical data --> |
|
| chemical_formula = (C<sub>26</sub>H<sub>40</sub>N<sub>2</sub>O<sub>36</sub>S<sub>5</sub>)<sub>n</sub> |
|
| chemical_formula = (C<sub>26</sub>H<sub>40</sub>N<sub>2</sub>O<sub>36</sub>S<sub>5</sub>)<sub>n</sub> |
|
| molecular_weight = 5500–6500 ] (average) |
|
| molecular_weight = 5500–6500 g/mol (average) |
|
}} |
|
}} |
|
|
|
|
|
'''Ardeparin''' (brand name '''Normiflo''') is an ]. It was used for the prevention of ], but was withdrawn from the US market in 2000 for reasons unrelated to safety or efficacy.<ref>{{cite book | vauthors = Frishman WH, Cheng-Lai A, Chen J |title=Current cardiovascular drugs |date=2000 |publisher=Current Medicine |location=Philadelphia, Pa. |isbn=978-1-4615-6767-7 |page=90 |edition=3rd | chapter = Antithrombotic therapy | chapter-url=https://books.google.com/books?id=zP7jBwAAQBAJ&pg=PA90 }}</ref><ref>{{cite web | work = Drugs.com | url = https://www.drugs.com/mtm/normiflo.html | title = Normiflo | access-date = 23 January 2018 | archive-date = 19 February 2017 | archive-url = https://web.archive.org/web/20170219170906/https://www.drugs.com/mtm/normiflo.html | url-status = dead }}</ref><ref>{{cite web |title=Determination That Ardeparin Sodium Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |url=https://www.federalregister.gov/d/02-12874 |website=United States Food and Drug Administration |date=23 May 2002 |publisher=Federal Register |access-date=24 June 2022}}</ref> |
|
|
|
|
|
==References== |
|
|
{{reflist}} |
|
|
|
|
|
{{Antithrombotics}} |
|
|
{{Portal bar | Medicine}} |
|
|
|
|
|
] |
|
|
] |
|
|
|
|
|
|
|
|
{{blood-drug-stub}} |